Trial intelligence / Profile preview

Effect of Itraconazole on PF-07248144 Pharmacokinetics in Healthy Participants

NCT07335419Phase 1Completed

Sponsor
Pfizer
Start
Jan 2026
Primary completion
Feb 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of prifetrastat, sponsored by Pfizer. Primary endpoints: Area under the concentration-time curve from time zero to extrapolated infinite time, Area under the concentration-time curve from time zero to time of last measurable concentration and 1 more. Started Jan 2026; status: completed.

02

Drugs

prifetrastat

Beyond the preview

Go deeper on NCT07335419.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07335419.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call